[Lys40(Ahx-DTPA-111In)NH2]-Exendin-4 is a highly efficient radiotherapeutic for glucagon-like peptide-1 receptor-targeted therapy for insulinoma. (Q53332122)
Jump to navigation
Jump to search
scientific article published in June 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | [Lys40(Ahx-DTPA-111In)NH2]-Exendin-4 is a highly efficient radiotherapeutic for glucagon-like peptide-1 receptor-targeted therapy for insulinoma. |
scientific article published in June 2007 |
Statements
[Lys40(Ahx-DTPA-111In)NH2]-Exendin-4 is a highly efficient radiotherapeutic for glucagon-like peptide-1 receptor-targeted therapy for insulinoma. (English)
1 reference
1 reference
Martin Behe
1 reference
Damian Wild
1 reference
Daniel Storch
1 reference
Christian Seemayer
1 reference
Martin Gotthardt
1 reference
Stefan Kneifel
1 reference
Michael J Mihatsch
1 reference
Jean-Claude Reubi
1 reference
Helmut R Mäcke
1 reference
Gerhard Christofori
1 reference
1 June 2007
1 reference
13
1 reference
12
1 reference
3696-3705
1 reference
Identifiers
1 reference